KZA 0.00% 8.0¢ kazia therapeutics limited

Novogen to announce potential treatment for Facioscapulohumeral Muscular Dystrophy?, page-4

  1. 54 Posts.
    This poster is yet to be presented. It will be presented by Dr. Stephen Palmer (head of Novogen's degenerative disease programs) during the American Society for Human Genetics meeting from Oct. 6 - 10.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.